Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Vocal Outcomes After Cell-Based Outer Vocal Fold Implant in Porcine Bilateral Vocal Fold Resection.

Zhang K., Crane G., Alvarez MR., Klomhaus A., Alhiyari Y., Gowda B.

Laboratory Study with a reported sample of 8 on Chronic Wound, published in Laryngoscope (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Laryngoscope (2026)
Country
United States
Reported sample size
8
Source database
PubMed
PMID
42439582
DOI
10.1002/lary.70738

Abstract (original English)

Cell-based outer vocal fold replacement (COVR) consists of human adipose-derived stem cells and is a potential treatment for severe vocal fold injury. Prior rabbit studies demonstrated enhanced wound healing and COVR's safety in pigs. Building on prior work defining pig-specific acoustic parameters, this study evaluates phonatory recovery and establishes quantitative voice assessment frameworks following bilateral cordectomy and COVR implantation in a large animal model. COVR implantation was performed in eight Yucatan mini-pigs after bilateral vocal fold resection. Functional voice recovery was tracked, with spontaneous vocalizations recorded pre- and post-surgery for up to 6 months. Pig squeals were extracted using Python, manually verified, and nonrepresentative sounds excluded. Acoustic features including Q50 (median frequency of spectral energy), flux (rate of spectral energy change), F0 (fundamental frequency), jitter (period perturbation), and shimmer (amplitude perturbation) were analyzed using linear mixed-effect models and Wilcoxon rank sum test with Benjamini-Yekutieli correction. After 6 months, larynges were harvested and human cells were sought via fluorescent in situ hybridization. Q50 significantly decreased immediately postoperatively (p < 0.001) and returned to preoperative range by 6 months, while F0 and flux changed modestly over time. Human cells persisted

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research